Seqens Seqens

X

Digital content for Cheplapharm Arzneimittel Gmbh

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Cheplapharm Arzneimittel Gmbh
Germany Flag
Country
Country
Germany
Address
Address
BAHNHOFSTR. 1A
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.cheplapharm.com/en/press-news/news-detail/cheplapharm-places-notes-in-a-volume-of-eur750m-in-challenging-market-environment/

PRESS RELEASE
28 Apr 2023

https://www.indianpharmapost.com/news/cheplapharm-selects-generis-cara-life-sciences-platform-to-unify-their-clinical-processes-13626

INDIANPHARMAPOST
20 Jan 2023

https://www.astellas.com/en/news/17036

PRESS RELEASE
16 Jun 2021

https://www.astrazeneca.com/media-centre/press-releases/2021/atacand-divestment-in-over-70-countries-completed.html#:~:text=AstraZeneca%20has%20completed%20the%20divestment,Cheplapharm%20Arzneimittel%20GmbH%20(Cheplapharm)

PRESS RELEASE
04 Jan 2021

https://www.reuters.com/article/us-astrazeneca-divestment/astrazeneca-sells-commercial-rights-to-two-drugs-in-400-million-deal-idUSKBN27F0VD

A. Jagadeesh REUTERS
31 Oct 2020

https://www.businesswire.com/news/home/20200831005238/en/LEO-Pharma-Sells-Portfolio-Products-Cheplapharm

BUSINESSWIRE
04 Sep 2020

https://www.businesswire.com/news/home/20200831005238/en/LEO-Pharma-Sells-Portfolio-Products-Cheplapharm

BUSINESSWIRE
03 Sep 2020

https://www.businesswire.com/news/home/20200831005238/en

BUSINESSWIRE
31 Aug 2020

https://www.pharmaceutical-technology.com/news/leo-pharma-cheplapharm-deal/

PHARMACEUTICAL TECHNOLOGY
31 Aug 2020

https://www.fiercepharma.com/pharma/astrazeneca-sells-u-s-canada-seroquel-rights-to-cheplapharm-for-up-to-42m

E. Sagonowsky FIERCE PHARMA
04 Dec 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY